To improve the quality and the yield of monoclonal antibody production, ZXBio develops novel cell culturing technologies. All the monoclonal antibody products are produced using hybridomas or CHO cell lines under serum-free culturing conditions. ZXBio's optimized method (Patent Number: cn 201811187760.2) is superior to traditional ascites production method, which always contaminates the purified antibodies with host proteins. Using affinity purification, ZXBio is able to purify monoclonal antibodies at a purity higher than 95% for research and in vitro diagnostic purposes.
ZXBio develops fluorescent labeling techniques in-house (Patent Number: cn 202010087828.0), all its fluorescent labeling antibodies are manufactured according to the highest industry standard (Pharmaceutical industry standard of the People's Republic of China, YY/T 1184-2010).
Antibody Production (Catalog: ZXSA0001): Contact for Price
LEAF(Endotoxin level < 0.01 Eu/ug) Antibody Production (Catalog: ZXSA0002): Contact for Price
Service:ZXBio applies in-house developed standard operational procedure (SOPs) to culture hybridomas or CHO cells in vitro. Through our in vitro culture procedure, ZXBio's purified antibodies give consistent yield and high purity. The yield per liter cell culture ranges from 15~115mg monoclonal antibodies, and our production period is typically between 4 to 7 weeks.
Hybridomas Service (Catalog: ZXSA0003): Contact for Price
Service:ZXBio applies in-house developed standard operational procedure (SOPs) to generate novel hybridomas with high-quality and high-yield antibody production. ZXBio immunizes mice to generate high-affinity mouse antibodies. The whole service process takes 120 days.
1. Protein Antigen: at least 2mg, purity higher than 85%
2. Peptide Antigen: at least 4mg, purity higher than 90%
3. Small molecule Antigen: at least 5mg, purity higher than 90%